Added Value of Anti-CD74 Autoantibodies in Axial SpondyloArthritis in a Population With Low HLA-B27 Prevalence
Axial spondyloarthritis (axSpA) is often diagnosed late due to the non-specific nature of its main symptom [chronic back pain (CBP)] and to the paucity of diagnostic markers, particularly in regions with low HLA-B27 prevalence, such as the Middle-East. We tested the performance of IgG4 and IgA anti-...
Main Authors: | Nelly R. Ziade, Iyad Mallak, Georges Merheb, Pierre Ghorra, Niklas Baerlecken, Torsten Witte, Xenofon Baraliakos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00574/full |
Similar Items
-
Autoantibodies in Spondyloarthritis, Focusing on Anti-CD74 Antibodies
by: Yuan Liu, et al.
Published: (2019-01-01) -
Axial Spondyloarthritis: An Evolving Concept
by: Nelly Ziadé
Published: (2015-07-01) -
Treat to Target in Spondyloarthritis: Myth or Reality?
by: Nelly Ziade, et al.
Published: (2021-07-01) -
The Role of Imaging in Diagnosing Axial Spondyloarthritis
by: Nikita Khmelinskii, et al.
Published: (2018-04-01) -
Early Recognition and Treatment of Spondyloarthritis: A Timeless Challenge
by: antiago Rodrigues Manica, et al.
Published: (2020-07-01)